330 likes | 1.66k Views
PFIZER´S MOVE TO THE CLOUD Clinical Aggregation Layer (CAL) . Rich Levin, Director , R&D Business Technology, Pfizer Oracle Open World September 2013.
E N D
PFIZER´S MOVE TO THE CLOUD Clinical Aggregation Layer (CAL) Rich Levin, Director, R&D Business Technology, Pfizer Oracle Open World September 2013
Disclaimer: This presentation outlines a general technology direction. Pfizer Inc has no obligation to pursue any approaches outlined in this presentation or to develop or use any functionality mentioned in this presentation. The technology strategy and possible future developments are subject to change and may be changed at any time for any reason without notice.
“INSANITY IS DOING THE SAME THING OVER AND OVER AGAIN AND EXPECTING DIFFERENT RESULTS”
The Solution Engine for Sustainable Innovation and Predictable Quality TechnologySolution Industry Leading R&D Operations Data Without Borders Information Process Optimized Business Operations Enabled by Technology and Information
Pfizer Long Term Technology Vision ICON Systems Future Acquisitions/ Future Partners Pfizer Run Studies Parexel Systems (PXL / ICON / FSP) On-going Studies: [OC/RDC/ TMS] Pfizer Information eXchange Hub (IXH) Pfizer owned and operated systems Contextual Reference Data Module (RDM) Safety Operational Data Warehouse (ODW) Clinical Scientific Data Warehouse (CSDW) • Trial Master File (TMF) Clinical Supply Aggregate Reporting Visualization Data Mining Study Operational Reports Program/portfolio milestones Partnership Scorecard Project Mgmt Others Accenture/Oracle Clinical Aggregation Layer
Technology Components To Provide a Simple, High Quality User Experience • Operational and scientific data warehouse / aggregation environment • Standards used across company, partners and external collaborators • Dynamic analytics via metadata-driven transformation • Orchestrated data exchange • Cloud computing–virtual instances of applications to minimize support burden • Agile on / off-boarding process – • identity and role driven access to applications, data, and projects • Appropriate monitoring, auditing, and reporting • Federated Single-Sign-On (SSO)
What will the new platform enable? • Consistent and comprehensive data access • Improved compliance • Greater efficiency • Actionable insight • Improved development in a collaborative environment • Scalability
Imagine a world… • With a shared industry infrastructure. • With the ability to seamlessly integrate data. • With the increased ability of data analytics and insights. • Where Clinical Trial Software and Infrastructure is provided as a service. • Where drug development costs are less…